These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 24727467

  • 1. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A, Schubert-Bast S, Reese JP, Rosenow F, Stephani U, Boor R.
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [Abstract] [Full Text] [Related]

  • 4. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
    Elliott J, McCoy B, Clifford T, Wells GA, Coyle D.
    Pharmacoeconomics; 2018 Oct; 36(10):1253-1261. PubMed ID: 29761351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
    Buck ML, Goodkin HP.
    Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Myers KA, Lightfoot P, Patil SG, Cross JH, Scheffer IE.
    Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y, Ohtsuka Y, STP-1 Study Group.
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [Abstract] [Full Text] [Related]

  • 17. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    Trivisano M, Specchio N, Vigevano F.
    Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
    [Abstract] [Full Text] [Related]

  • 18. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y, Ohtsuka Y, Oguni H, Tohyama J, Baba H, Fukushima K, Ohtani H, Takahashi Y, Ikeda S.
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [Abstract] [Full Text] [Related]

  • 19. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.